<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01777607</url>
  </required_header>
  <id_info>
    <org_study_id>Recover Right</org_study_id>
    <nct_id>NCT01777607</nct_id>
  </id_info>
  <brief_title>The Use of Impella RP Support System in Patients With Right Heart Failure</brief_title>
  <official_title>The Use of Impella RP Support System in Patients With Right Heart Failure: A Clinical and Probable Benefit Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abiomed Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abiomed Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of Impella RP is safe, feasible and provides a hemodynamic benefit in patients with
      right ventricular failure.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Benefit Endpoint</measure>
    <time_frame>30 Days</time_frame>
    <description>Survival at 30 days or hospital discharge whichever is longer post device explant or to the next therapy, including transplant, bridge to transplant or destination therapy with FDA approved surgical VAD (Ventricular Assit Device).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Right Heart Failure</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IMPELLA® RP</intervention_name>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients that have developed signs of right ventricular failure either: A) within 48
             hours post-implantation of an FDA approved implantable surgical LVAD (left ventricular
             assist device )(Cohort A) or B) subsequent to postcardiotomy shock within 48 hours
             post surgery or post myocardial infarction (Cohort B).

          2. Age ≥18 years old

          3. Signed Informed consent

        Exclusion Criteria

          1. INTERMACS 1 patients (Critical cardiogenic shock patient who is &quot;crashing and
             burning&quot;, has life-threatening hypotension and rapidly escalating inotropic or pressor
             support, with critical organ hypoperfusion often confirmed by worsening acidosis and
             lactate levels)

          2. Evidence of acute neurologic injury

          3. RA(right atrium),RV (right Ventricle) and/or PA (pulmonary artery) thrombus

          4. Intolerance to anticoagulant or antiplatelet therapies

          5. Existing congenital heart disease that would preclude the insertion of the device.

          6. Participation in any other clinical investigation that is likely to confound study
             results or affect study outcome

          7. Acute Myocardial Infarction (AMI) with mechanical complications ( ventricular septal
             defect, myocardial rupture, papillary muscle rupture)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William O.Neill, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Henry Ford Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Anderson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Fox, RN</last_name>
      <phone>313-916-1879</phone>
      <email>mfox2@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>William O'Neill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Albert Einstein Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maggie Flynn</last_name>
      <phone>267-421-7439</phone>
      <email>FlynnMag@einstein.edu</email>
    </contact>
    <investigator>
      <last_name>Mark Anderson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2013</study_first_submitted>
  <study_first_submitted_qc>January 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2013</study_first_posted>
  <last_update_submitted>May 11, 2013</last_update_submitted>
  <last_update_submitted_qc>May 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

